Early detection of diabetic foot with Neuropad®;Diabetische fußveränderungen früh erkennen mit farbindikatortest Neuropad®

Diabetes, Stoffwechsel und Herz

Volumn 17, Issue 3, 2008, Pages 203-210

  Schnell, Oliver ^a   Muller M ^b   Standl, E ^a  

^a INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

^b Abteilung Diabetologie   (Germany)

Author keywords

Colour coding indicator pad Neuropad screening test; Diabetic foot syndrome; Prevention

Indexed keywords

DIABETIC FOOT; DIABETIC PATIENT; FOOT AMPUTATION; HEALTH CARE COST; HUMAN; PATIENT ASSESSMENT; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; SCREENING TEST; SWEATING;

EID: 49149131901     PISSN: 18617603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Diabetes Care and Research in Europe: The St. Vincent Declaration. Diabet Med 1990; 7: 360-362
2. Lawall H: Diabetes und Fußerkrankungen. In: Deutsche Diabetes-Union: Deutscher Gesundheitsbericht Diabetes 2008: 86-93
3. Bailey TS, Yu HM, Rayfield EJ: Patterns of foot examination in a diabetes clinic. Am J Med 1985; 78: 371-374
4. Boulton AJ, Betts RP, Franks CI, Newrick PG, Ward JD, Duckworth T: Abnormalities of foot pressure in early diabetic neuropathy. Diabet Med 1987; 4: 225-228
5. De Berardis G, Pellegrini F, Franciosi M, Belfiglio M, Di Nardo B, Greenfield S, Kaplan SH, Rossi MC, Sacco M, Tognoni G, Valentini M, Nicolucci A: QuED Study Group - Quality of Care and Outcomes in Type 2 Diabetes. Are Type 2 diabetic patients offered adequate foot care? The role of physician and patient characteristics. J Diabetes Complications 2005; 19: 319-327
6. Bell ET: Atherosclerotic gangrene of the lower extremities in diabetic and nondiabetic persons. Am J Clin Pathol 1957; 28: 27-34
7. Bild DE, Selby JV, Sinnock P, Browner WS, Braverman P, Showstack JA: Lower-extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care 1989; 12: 24-31
8. Deerodianawong C, Home PD, Alberti KGMM: A survey of lower limb amputation in diabetic patients. Diabet Med 1992; 9: 942-946
9. Ecker ML, Jacobs BS: Lower extremity amputation in diabetic patients. Diabetes 1970; 19: 189-195
10. Ferrier TM: Comparative study of arterial disease in amputated lower limbs from diabetics and nondiabetics (with special reference to feet arteries). Med J Aust 1967; 1: 5-8
11. Humphrey LL, Palumbo PJ, Butters MA: The contribution of non-insulin-dependent diabetes to lower extremity amputation in the community. Arch Intern Med 1994; 154: 885-892
12. Reike H: Schwerpunkt Fußklinik - Qualitätsstandards verhindern Amputationen. Schulungsprofi Diabetes 1997; 46 (3): 14-20
13. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyörälä K: Lower extremity amputation in diabetic and nondiabetic patients. Diabetes Care 1993; 16: 16-20
14. Standl E, Mendler G, Zimmermann R, Stiegler H: Zur Amputationshä ufigkeit von Diabetikern in Deutschland. Ergebnisse einer Erhebung in zwei Landkreisen. Diabetes und Stoffwechsel 1996; 5: 29-32
15. Stiegler H, Standl E, Frank S, Mendler G: Failure of reducing lower extremity amputations in diabetic patients: results of two subsequent population-based surveys 1990 and 1995 in Germany. Vasa 1998; 27: 10-14
16. The LEA Study Group: Comparing the incidence of lower extremity amputations across the world: the global lower extremity amputation study. Diabet Med 1995; 12: 14-18
17. Waugh NK: Amputations in diabetic patients - a review of rates, relative risks and resource use. Community Med 1988; 10: 279-288
18. von Ferber L, Rathmann W, Köster I, König M: Diabetespatienten und ihre primärärztliche Versorgung. Komplikationen und Mortalität anhand der Daten einer AOK. In: Laaser U, Schwartz FW (Hrsg.): Gesundheitsberichterstattung und Public Health in Deutschland. Springer, Berlin, Heidelberg, 1992: 255-266
19. Hauner H, von Ferber L: Qualität der Versorgung von Diabetikern. Eine Analyse von Krankenkassendaten. Diabetes und Stoffwechsel 1996; 5: 27-30
20. Jönsson B, Persson U: Diabetes - eine gesundheitsökonomische Studie. Swedish Institute for Health Economics, Kopenhagen, 1981: 1-114
21. Standl E: Zur Epidemiologie des diabetischen Fußsyndroms. Diabetes und Stoffwechsel 2000; 9: 339-342
22. Trautner C, Standl E, Haastert B, Giani G, Berger M: Geschätzte Anzahl von Amputationen in Deutschland. Diabetes und Stoffwechsel 1997; 6: 199-202
23. Spraul M, Schönbach AM, Mühlhauser I, Berger M: Amputationen und Mortalität bei älteren, insulinpflichtigen Patienten mit Typ 2-Diabetes. Zentralbl Chir 1999; 124: 25-31
24. Spraul M: Prävention des diabetischen Fußsyndroms. Internist 1999; 40: 1056-1066
25. Heller G, Günster C, Schellschmidt H: Wie häufig sind Diabetes-bedingte Amputationen unterer Extremitäten in Deutschland? Eine Analyse auf Basis von Routinedaten. Dtsch Med Wochenschr 2004; 129: 429-433
26. van Houtum WH, Lavery LH: Outcomes associated with diabetes-related amputations in the Netherlands and the State of California. J Int Med 1996; 240: 227-231
27. Calle-Pascual AL, Redondo MJ, Ballesteros M: Nontraumatic lower extremity in diabetic and nondiabetic subjects in Madrid, Spain. Diabet Metab 1997; 23: 519-523
28. Madani SF, Stammler C, Muller UA: The frequency of lower-limb amputations in people with diabetes in the German state of Thuringia. Diabetes und Stoffwechsel 1999; 8: 201-206
29. Holstein P, Ellitsgaard N, Olsen BB, Ellitsgaard V: Decreasing incidence of major amputations in people with diabetes. Diabetologia 2000; 43: 844-847
30. Calle-Pascual AL, Garcia-Torre N, Moraga I: Epidemiology of nontraumatic lower extremity amputation in Area 7, Madrid, between 1989 and 1999. Diabetes Care 2001; 24: 1686-1689
31. Trautner C, Haastert B, Spraul M, Giani G, Berger M: Unchanged incidence of lower-limb amputations in a German city, 1990-1998. Diabetes Care 2001; 24: 855-859
32. Bollinger A: Funktionelle Angiologie. Thieme, Stuttgart, New York, 1979
33. Boulton AJM: The diabetic foot: neuropathic in aetiology? Diabet Med 1990; 7: 852-858
34. Chantelau E, Kleinfeld H, Paetow P: Das Syndrom des "diabetischen Fußes". Diabetes und Stoffwechsel 1992; 1: 18-23
35. Chantelau E: Amputation? Nein danke! Kirchheim, Mainz, 1995
36. Edmonds ME, Watkins PJ: The diabetic foot. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P: International Textbook of Diabetes Mellitus. Wiley, Chichester, 1992: 1535-1548
37. Hepp WW: Der diabetische Fuß. Blackwell, Oxford, 1996: 1-195
38. Levin MD, O'Neal LW: The Diabetic Foot. Mosby, St. Louis, 1988
39. Schnell O, Standl E: Von entscheidender Bedeutung: Differentialdiagnose bei Fußläsion - Neuropathie oder arterielle Verschlußkrankheit. Klinik-Magazin 1996, 12 (Sonderheft 8-12)
40. LoGerfo FW, Coffman JD: Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984; 311: 1615-1619
41. Tooke JE, Brash PD: Microvascular Aspects of Diabetic Foot Disease. Diabet Med 1996, 13: S26-S29
42. Apelqvist J, Ragnarsson-Tennvall G, Persson U, Larsson J: Diabetic foot ulcers in a multidisciplinary setting - an economic analysis of primary healing and healing with amputation. J Int Med 1994; 235: 463-471
43. Gordois A, Scuffham P, Shearer A: The Health Care Costs of Diabetic Peripheral Neuropathy in the U.S. Diabetes Care 2003; 26: 1790-1795
44. Standl E, Stiegler H, Janka HU, Hillebrand B: Das diabetische Fußsyndrom. In: Mehnert H, Standl E, Usadel KH, Häring HU (Hrsg.): Diabetologie in Klinik und Praxis. Thieme, Stuttgart, New York, 2003: 579-605
45. Apelqvist J, Larsson J, Agardh CD: Long-term prognosis for diabetic patients with foot ulcers. J Int Med 1993; 233: 485-491
46. Litzelman D, Slemenda W, Langefeld C, Hays L, Welch A, Bild D: Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus, Ann of Intern Med 1993; 119: 36-41
47. McCabe CJ, Stevenson RC, Dolan AM: Evaluation of a diabetic foot screening and protection program. Diabetic Med 1998; 15: 80-84
48. Dargis V, Pantelejeva O, Jonushaite A: Benefits of a Multidisciplinary Approach in the Management of Recurrent Diabetic Foot Ulceration in Lithuania. A prospective study. Diabetes Care 1999; 22: 1428-1431
49. Internationale Arbeitsgruppe über den Diabetischen Fuß: Internationaler Konsensus über den Diabetischen Fuß. Kirchheim, Mainz, 1999
50. American Diabetes Association: Standards of Medical Care in Diabetes - 2008. Diabetes Care 2008; 31: S12-S54
51. Zick R, Schäper T, Deeters U: Early Detection of Peripheral Diabetic Neuropathy - Measurement of Perspiration in the Diabetic Foot. Klinikarzt 2003; 32: 288-290, DOI: 10.1055/s-2003-42191
52. Zick R, Hilling A: Untersuchungen zur Hauttrockenheit beim diabetischen Fußsyndrom. Z Allg Med 1999; 75: 240-243
53. Papanas N, Papatheodorou K, Christakidis D, Papazoglou D, Giassakis G, Piperidou H, Monastiriotis C, Maltezos E: Evaluation of a new indicator test for sudomotor function (Neuropad) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 2005; 113: 195-198
54. Manes C, Kirlaki E, Papantoniou S, Sossidou E, Skoutas D, Tsotoulidis S, Kefalogiannis N, Sion M: Neuropad: Validation of a new indicator plaster as a screening tool in identifying patients at risk of foot ulceration - a multicenter study. Diabetic Foot Study Group. Elsinore, Denmark, 10-13 September 2006
55. Shen J, Cao Y, Han YJ, Luo XR, Xie CH, Li JM, Xue YM: Sweat function evaluation for early diagnosis of diabetic peripheral neuropathy. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 1210-1212
56. Papanas N, Papatheodorou K, Papazoglou D, Christakidis D, Monastiriotis C, Maltezos E: Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication. Exp Clin Endocrinol Diabetes 2005; 113: 577-581
57. Papanas N, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Maltezos E: A Comparison of the New Indicator Test for Sudomotor Function (Neuropad®) with the Vibration Perception Threshold and the Clinical Examination in the Diagnosis of Peripheral Neuropathy in Subjects with Type 2 Diabetes. Exp Clin Endocrinol Diabetes 2007; 20; (Epub ahead of print)
58. Bilen H, Atmaca A, Akcay G: Neuropad indicator test for diagnosis of sudomotor dysfunction in type 2 diabetes. Adv Ther 2007; 24: 1020-1027
59. Liatis S, Marinou K, Tentolouris N, Pagoni S, Katsilambros N: Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus. Diabet Med 2007; 24: 1375-1380. Epub 2007 Oct 17
60. Papanas N, Giassakis G, Papatheodorou K, Papazoglou D, Monastiriotis C, Christakidis D, Piperidou H, Maltezos E: Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications 2007; 21: 353-358
61. Tentolouris N, Achtsidis V, Marinou K, Katsilambros N: Evaluation of the Self-administered Indicator Plaster Neuropad for the Diagnosis of Neuropathy in Diabetes. Diabetes Care 2007 Dec 4; (Epub ahead of print)
62. Quattrini C, Jeziorska M, Boultonn AJM, Malik RA: Validation of Neuropad: A Visual indicator test for human diabetic neuropathy. Diabetologia 2008. Im Druck
63. Morbach S, Müller E, Reike H, Risse A, Spraul M: Diagnostik, Therapie, Verlaufskontrolle und Prävention des diabetischen Fußsyndroms. Diabetes und Stoffwechsel 2004; 13: 11